Diabetic autonomic neuropathy.
Vinik AI, Maser RE, Mitchell BD, Freeman R.
Diabetes Care. 2003 May;26(5):1553-79. doi: 10.2337/diacare.26.5.1553.
Hyperglycemia.
Mouri M, Badireddy M.
2023 Apr 24. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–.
Prediabetes: Beyond the Borderline.
Wilson ML.
Nurs Clin North Am. 2017 Dec;52(4):665-677. doi: 10.1016/j.cnur.2017.07.011. Epub 2017 Oct 5.
Epidemiology of risk factors for cardiovascular disease in diabetes and impaired glucose tolerance.
Laakso M, Lehto S.
Atherosclerosis. 1998 Apr;137 Suppl:S65-73. doi: 10.1016/s0021-9150(97)00314-6.
Polyneuropathy with Impaired Glucose Tolerance: Implications for Diagnosis and Therapy.
Singleton JR, Smith AG, Russell J, Feldman EL.
Curr Treat Options Neurol. 2005 Jan;7(1):33-42. doi: 10.1007/s11940-005-0004-4.
Detecting diabetes and impaired glucose tolerance in patients with atherosclerotic peripheral arterial disease.
Green FC, Levison R, Newton DJ, Littleford R, Stonebridge PA, Belch JJ.
Int Angiol. 2012 Apr;31(2):125-8.
Elevated remnant cholesterol and atherosclerotic cardiovascular disease in diabetes: a population-based prospective cohort study.
Wadström BN, Pedersen KM, Wulff AB, Nordestgaard BG.
Diabetologia. 2023 Dec;66(12):2238-2249. doi: 10.1007/s00125-023-06016-0. Epub 2023 Sep 30.
Stroke and Diabetes.
Pikula A, Howard BV, Seshadri S.
In: Cowie CC, Casagrande SS, Menke A, Cissell MA, Eberhardt MS, Meigs JB, Gregg EW, Knowler WC, Barrett-Connor E, Becker DJ, Brancati FL, Boyko EJ, Herman WH, Howard BV, Narayan KMV, Rewers M, Fradkin JE, editors. Diabetes in America. 3rd edition. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases (US); 2018 Aug. CHAPTER 19.
Acarbose for the prevention of diabetes, hypertension, and cardiovascular disease in subjects with impaired glucose tolerance: the Study to Prevent Non-Insulin-Dependent Diabetes Mellitus (STOP-NIDDM) Trial.
Chiasson JL.
Endocr Pract. 2006 Jan-Feb;12 Suppl 1:25-30. doi: 10.4158/EP.12.S1.25.
The Efficacy of HGF/VEGF Gene Therapy for Limb Ischemia in Mice with Impaired Glucose Tolerance: Shift from Angiogenesis to Axonal Growth and Oxidative Potential in Skeletal Muscle.
Stafeev I IS, Boldyreva MA, Michurina SS, Agareva MY, Radnaeva AV, Menshikov MY, Hu YC, Makarevich PI, Parfyonova YV.
Cells. 2022 Nov 29;11(23):3824. doi: 10.3390/cells11233824.
